Literature DB >> 29340484

Evolution in the management of non-small cell lung cancer in Brazil.

Caio Júlio Cesar Dos Santos Fernandes1,2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29340484      PMCID: PMC5792035          DOI: 10.1590/S1806-37562017000060002

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  17 in total

Review 1.  New anticoagulants for the treatment of venous thromboembolism.

Authors:  Caio Julio Cesar Dos Santos Fernandes; José Leonidas Alves Júnior; Francisca Gavilanes; Luis Felipe Prada; Luciana Kato Morinaga; Rogerio Souza
Journal:  J Bras Pneumol       Date:  2016-04       Impact factor: 2.624

Review 2.  Biomarkers in lung adenocarcinoma: a decade of progress.

Authors:  Lynette M Sholl
Journal:  Arch Pathol Lab Med       Date:  2014-09-25       Impact factor: 5.534

3.  Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Thomas B Richards; S Jane Henley; Mary C Puckett; Hannah K Weir; Bin Huang; Thomas C Tucker; Claudia Allemani
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

Review 4.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

5.  Endobronchial ultrasound in real life: primary diagnosis and mediastinal staging of lung cancer in patients submitted to thoracic surgery.

Authors:  João Pedro Steinhauser Motta; Axel Tobias Kempa; Alexandre Pinto Cardoso; Marcos Eduardo Paschoal; Ronir Raggio Luiz; José Roberto Lapa E Silva; Franz Stanzel
Journal:  BMC Pulm Med       Date:  2016-07-19       Impact factor: 3.317

6.  Factors associated with disease-specific survival of patients with non-small cell lung cancer.

Authors:  Mirian Carvalho de Souza; Oswaldo Gonçalves Cruz; Ana Glória Godoi Vasconcelos
Journal:  J Bras Pneumol       Date:  2016 Sep-Oct       Impact factor: 2.624

7.  Cancer mortality predictions for 2017 in Latin America.

Authors:  G Carioli; C La Vecchia; P Bertuccio; T Rodriguez; F Levi; P Boffetta; E Negri; M Malvezzi
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

8.  Anatomic pulmonary resection by video-assisted thoracoscopy: the Brazilian experience (VATS Brazil study).

Authors:  Ricardo Mingarini Terra; Thamara Kazantzis; Darcy Ribeiro Pinto-Filho; Spencer Marcantonio Camargo; Francisco Martins-Neto; Anderson Nassar Guimarães; Carlos Alberto Araújo; Luis Carlos Losso; Mario Claudio Ghefter; Nuno Ferreira de Lima; Antero Gomes-Neto; Flávio Brito-Filho; Rui Haddad; Maurício Guidi Saueressig; Alexandre Marcelo Rodrigues Lima; Rafael Pontes de Siqueira; Astunaldo Júnior de Macedo E Pinho; Fernando Vannucci
Journal:  J Bras Pneumol       Date:  2016 May-Jun       Impact factor: 2.624

9.  Survival in a cohort of patients with lung cancer: the role of age and gender in prognosis.

Authors:  Juliana Pereira Franceschini; Sérgio Jamnik; Ilka Lopes Santoro
Journal:  J Bras Pneumol       Date:  2017 Nov-Dec       Impact factor: 2.624

10.  Robotic pulmonary lobectomy for lung cancer treatment: program implementation and initial experience.

Authors:  Ricardo Mingarini Terra; Pedro Henrique Xavier Nabuco de Araujo; Leticia Leone Lauricella; José Ribas Milanez de Campos; Herbert Felix Costa; Paulo Manuel Pego-Fernandes
Journal:  J Bras Pneumol       Date:  2016 May-Jun       Impact factor: 2.624

View more
  2 in total

1.  Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology.

Authors:  Ziqi Meng; Xinkui Liu; Jiarui Wu; Wei Zhou; Kaihuan Wang; Zhiwei Jing; Shuyu Liu; Mengwei Ni; Xiaomeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-28       Impact factor: 2.629

Review 2.  Extended anticoagulation after venous thromboembolism: should it be done?

Authors:  Caio J Fernandes; Daniela Calderaro; Bruna Piloto; Susana Hoette; Carlos Vianna Poyares Jardim; Rogério Souza
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.